| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c67268a57118696b90da2df1945cec99 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 |
| filingDate |
2015-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b08f4a9c4e9424448dcf4c91d6947a4 |
| publicationDate |
2017-03-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-106478596-A |
| titleOfInvention |
A new compound as a treatment for ophthalmic diseases |
| abstract |
The present invention relates to a topical ophthalmic pharmaceutical composition containing axitinib prodrug, its preparation and its use for the treatment of ophthalmic disorders. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112442009-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112442009-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112442010-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112442010-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112442011-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2022512687-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7295944-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021035360-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021037183-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020254606-A1 |
| priorityDate |
2015-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |